Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

A built-in adjuvant-engineered mucosal vaccine against dysbiotic periodontal diseases.

Puth S, Hong SH, Na HS, Lee HH, Lee YS, Kim SY, Tan W, Hwang HS, Sivasamy S, Jeong K, Kook JK, Ahn SJ, Kang IC, Ryu JH, Koh JT, Rhee JH, Lee SE.

Mucosal Immunol. 2019 Mar;12(2):565-579. doi: 10.1038/s41385-018-0104-6. Epub 2018 Nov 28.

PMID:
30487648
2.

More robust gut immune responses induced by combining intranasal and sublingual routes for prime-boost immunization.

Hwang HS, Puth S, Tan W, Verma V, Jeong K, Lee SE, Rhee JH.

Hum Vaccin Immunother. 2018;14(9):2194-2202. doi: 10.1080/21645515.2018.1472185. Epub 2018 Jun 19.

3.

Mucosal immunization with a flagellin-adjuvanted Hgp44 vaccine enhances protective immune responses in a murine Porphyromonas gingivalis infection model.

Puth S, Hong SH, Park MJ, Lee HH, Lee YS, Jeong K, Kang IC, Koh JT, Moon B, Park SC, Rhee JH, Lee SE.

Hum Vaccin Immunother. 2017 Dec 2;13(12):2794-2803. doi: 10.1080/21645515.2017.1327109. Epub 2017 Jun 12.

4.

Norovirus (NoV) specific protective immune responses induced by recombinant P dimer vaccine are enhanced by the mucosal adjuvant FlaB.

Verma V, Tan W, Puth S, Cho KO, Lee SE, Rhee JH.

J Transl Med. 2016 May 17;14(1):135. doi: 10.1186/s12967-016-0899-4.

Supplemental Content

Support Center